• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Hong Kong·Healthcare·1134.HK
Share

Kelfred Holdings Limited Stocks

HK$ 0.35Last Updated 12.06.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

HK$ 22.34M

HK$ 0.35
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Kelfred Holdings Limited functions as an investment holding entity primarily engaged in the creation and sale of eyewear. The firm produces a diverse array of spectacle frames and sunglasses, largely leveraging original design manufacturing (ODM) and original equipment manufacturing (OEM) models. Its comprehensive offerings span from product conceptualization and sourcing of raw materials to the manufacturing process, rigorous quality assurance, packaging, and final distribution. Additionally, Kelfred markets its proprietary 'Miga' brand items and participates in the general trading of eyewear merchandise. Established in 1986 and headquartered in Sha Tin, Hong Kong, the company boasts a significant international presence, conducting operations across the People's Republic of China, Italy, the United Kingdom, the Netherlands, France, Spain, Hungary, the United States, and other global markets.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. In particular, the stock is 'expensive' on EV/EBITDA, underval

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.06.2026 02:48

US and Iran reach peace deal - Trump

14.06.2026 21:00

SpaceX debuts, OpenAI is one step closer to the stock exchange: highlights of the IPO by June 14

14.06.2026 18:01

ECB has raised rates, next move is for the Fed: what will be Kevin Warsh's first decision

14.06.2026 15:01

"A premium for candor": how top executives' comments affect companies' share prices

13.06.2026 22:31

U.S. and Iran to sign agreement on June 14, Strait of Hormuz to reopen - Trump

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026